Rexulti Sales by Indication
Rexulti (brexpiprazole) is approved for several indications, and sales figures are often reported in aggregate rather than broken down by specific use. However, the primary indications driving its sales are major depressive disorder (MDD) and schizophrenia.
How is Rexulti Used?
Rexulti is a prescription medication used to treat:
* Major depressive disorder (MDD) as an add-on treatment to antidepressants [1].
* Schizophrenia in adults and adolescents 13 years and older [1].
What Other Conditions Might Rexulti Treat?
While the primary approved uses are MDD and schizophrenia, research has explored Rexulti's potential in other areas, though these are not currently its main sales drivers.
When Does Rexulti's Patent Expire?
Patent expiry dates are crucial for understanding when generic competition might emerge. Information on Rexulti's specific patent status and expected expiry can be found through resources that track drug patents. For detailed information on Rexulti's patent landscape, DrugPatentWatch.com is a valuable resource [2].
Who Manufactures Rexulti?
Rexulti is manufactured by Otsuka Pharmaceutical Co., Ltd. [3].
How Do Rexulti Sales Compare to Similar Drugs?
Sales performance can be contextualized by comparing Rexulti to other atypical antipsychotics or adjunctive treatments for depression. However, direct sales comparisons by indication are not typically available publicly.
What Clinical Data Supports Rexulti's Use?
Clinical trials have demonstrated Rexulti's efficacy in treating both schizophrenia and as an adjunctive therapy for MDD. These studies form the basis for its regulatory approvals [1].
What Are the Risks and Side Effects of Rexulti?
Like all medications, Rexulti carries potential risks and side effects. Common side effects include weight gain, akathisia (restlessness), headache, and fatigue. Serious side effects can include an increased risk of death in elderly patients with dementia-related psychosis and suicidal thoughts and behaviors [1].
What Are Patient Concerns About Rexulti?
Patients often inquire about the effectiveness of Rexulti for their specific condition, potential side effects, and the duration of treatment. Concerns regarding weight gain and movement disorders like akathisia are frequently raised [1].
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206597s029,206598s025,209048s013lbl.pdf
[2] https://drugpatentwatch.com/
[3] https://www.otsuka.co.jp/en/